Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Wilson

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Plos One|December 22, 2016
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development PropertiesAndrew C Nyborg, Chris Ward, Anna Zacco, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancementJohn Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Nature Chemical Biology|October 25, 2016
Potent and selective bivalent inhibitors of BET bromodomainsMichael J Waring, Huawei Chen, Alfred A Rabow, et al.
Nature|July 31, 2012
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2013
The discovery of the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, et al.
Nature|October 4, 2014
Kruidenier et al. replyLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Journal of Medicinal Chemistry|August 18, 2025
In Pursuit of Best-in-Class MCL-1 Inhibitors: Discovery of Highly Potent 1,4-Indoyl Macrocycles with Favorable Physicochemical PropertiesIngrid Adriana Velter, William Lento, Aldo Peschiulli, et al.
Journal of Medicinal Chemistry|January 16, 2016
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one DerivativesSusan M Westaway, Alex G S Preston, Michael D Barker, et al.
Research Square|November 24, 2025
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Plos One|December 22, 2016
A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development PropertiesAndrew C Nyborg, Chris Ward, Anna Zacco, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2012
The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancementJohn Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Nature Chemical Biology|October 25, 2016
Potent and selective bivalent inhibitors of BET bromodomainsMichael J Waring, Huawei Chen, Alfred A Rabow, et al.
Nature|July 31, 2012
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2013
The discovery of the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, et al.
Nature|October 4, 2014
Kruidenier et al. replyLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Journal of Medicinal Chemistry|August 18, 2025
In Pursuit of Best-in-Class MCL-1 Inhibitors: Discovery of Highly Potent 1,4-Indoyl Macrocycles with Favorable Physicochemical PropertiesIngrid Adriana Velter, William Lento, Aldo Peschiulli, et al.
Journal of Medicinal Chemistry|January 16, 2016
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one DerivativesSusan M Westaway, Alex G S Preston, Michael D Barker, et al.
Research Square|November 24, 2025
Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-βeta2Anju Wadhwa, Haley Johnson, Kondapa Naidu Bobba, et al.
Pageof 33